Repurposed drug improves outcomes for patients with severe COVID-19 pneumonia
17 July 2024
A drug used to treat cystic fibrosis improved outcomes for patients with severe COVID-19 pneumonia and could have further uses, according to clinical trial results from researchers at 皇家华人, UCLH and the Francis Crick Institute including Professor Joanna Porter (UCL Medicine).
Close
